MPHOSPH9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.137640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.293800E-01
Normal-vs-Stage2
4.239200E-01
Normal-vs-Stage3
2.700800E-01
Normal-vs-Stage4
5.069800E-01
Stage1-vs-Stage2
8.172200E-02
Stage1-vs-Stage3
7.186000E-02
Stage1-vs-Stage4
6.338600E-01
Stage2-vs-Stage3
3.683600E-03
Stage2-vs-Stage4
5.174400E-01
Stage3-vs-Stage4
1.858430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.373840E-01
Normal-vs-AfricanAmerican
2.974000E-01
Normal-vs-Asian
2.828800E-01
Caucasian-vs-AfricanAmerican
9.988000E-01
Caucasian-vs-Asian
6.868200E-02
AfricanAmerican-vs-Asian
1.165770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.264240E-01
Normal-vs-Female
1.235360E-01
Male-vs-Female
7.877200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.205000E-01
Normal-vs-Age(41-60Yrs)
2.770600E-01
Normal-vs-Age(61-80Yrs)
7.463700E-02
Normal-vs-Age(81-100Yrs)
1.374560E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.319200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.109600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.326400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.037900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.999150E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.420000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.456800E-01
Normal-vs-Daily Drinker
3.499400E-01
Normal-vs-Weekly Drinker
3.760000E-01
Normal-vs-Occasional Drinker
3.538600E-01
Normal-vs-Social Drinker
4.505800E-01
Non Drinker-vs-Daily Drinker
9.596800E-01
Non Drinker-vs-Weekly Drinker
7.443800E-01
Non Drinker-vs-Occasional Drinker
8.050100E-02
Non Drinker-vs-Social Drinker
9.834500E-02
Daily Drinker-vs-Weekly Drinker
7.835800E-01
Daily Drinker-vs-Occasional Drinker
1.123960E-01
Daily Drinker-vs-Social Drinker
1.100840E-01
Weekly Drinker-vs-Occasional Drinker
2.498400E-01
Weekly Drinker-vs-Social Drinker
1.867370E-01
Occasional Drinker-vs-Social Drinker
8.182800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.024200E-01
Normal-vs-Grade 2
5.009400E-01
Normal-vs-Grade 3
3.857600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.529200E-01
Grade 1-vs-Grade 3
9.860200E-01
Grade 1-vs-Grade 4
6.024200E-01
Grade 2-vs-Grade 3
2.780400E-01
Grade 2-vs-Grade 4
5.009400E-01
Grade 3-vs-Grade 4
3.857600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.012000E-01
Normal-vs-NonDiabetic
9.828400E-02
Diabetic-vs-NonDiabetic
8.122800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.145000E-01
Normal-vs-NoPancreatitis
1.127830E-01
Pancreatitis-vs-NoPancreatitis
2.522200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.706200E-01
Normal-vs-N1
4.302800E-01
N0-vs-N1
5.323000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.131800E-01
Normal-vs-TP53-NonMutant
3.791600E-01
TP53-Mutant-vs-TP53-NonMutant
1.037800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
